Skip to main content
. 2022 Jun 2;66(6):e00290-22. doi: 10.1128/aac.00290-22

FIG 5.

FIG 5

FIG 5

Trajectories of the development of resistance to ampicillin-sulbactam (A), piperacillin-tazobactam (B), and ceftazidime-avibactam (C). The accumulation of mutations over time is plotted from left to right. Numbers above the boxes indicate the concentrations of the antibiotic-inhibitor at which the respective population was selected.